Hormone Replacement Therapy and the General Practitioner [Report]
نویسندگان
چکیده
منابع مشابه
The menopause and hormone replacement therapy: views of women in general practice receiving hormone replacement therapy.
Women's views on the menopause and hormone replacement therapy were explored using a questionnaire given to women attending one general practice who were having hormone replacement therapy under the supervision of their doctor. Sixty four women (67%) responded. Although only 5% of women had requested hormone replacement therapy from their general practitioner the majority of women indicated tha...
متن کاملHormone replacement therapy: a survey of Irish general practitioners.
We report findings of a cross-sectional postal survey of current prescribing practices of hormone replacement therapy (HRT) by Irish General Practitioners from a random sample of 600 Irish College of General Practitioners members. Median estimated prescribing rate of HRT was 17.5% (interquartile range 10 to 30%). The majority of General Practitioners would prescribe for the prevention of osteop...
متن کاملSignificant fall in hormone replacement therapy prescription in general practice.
BACKGROUND Hormone replacement therapy (HRT) in the past has been used in one of five women but not without significant short-term and long-term consequences. Objective. The aim of the study is to assess the prescription of HRT in general practice to women consulting with menopausal symptoms, before and after publication of the Women's Health Initiative (WHI) study (2002), the Million Women Stu...
متن کاملHormone Replacement Therapy and Stroke
Despite major progress in treatment and prevention, stroke remains the leading cause of disability and the third leading cause of death, surpassed only by heart disease and cancer, in the United States.1 An estimated 500 000 to 600 000 first and 100 000 recurrent strokes occur each year, and '160 000 of these are fatal.2 Among stroke survivors, the burden of long-term disability is great. In th...
متن کاملHormone replacement therapy.
HRT is indicated for the treatment of moderate ▪ to severe vasomotor and urogenital symptoms associated with menopause. HRT is not recommended for primary prevention of ▪ disease because of increased risk of other adverse events. The use of HRT increases the risk of stroke, venous ▪ thromboembolism (VTE) and gall bladder disease and combined oestrogen progestogen therapy is also associated with...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Proceedings of the Royal Society of Medicine
سال: 1977
ISSN: 0035-9157
DOI: 10.1177/003591577707000616